Early viral entry assays for the identification and evaluation of antiviral compounds

Chen Jei Tai, Chia Lin Li, Cheng Jeng Tai, Chien Kai Wang, Liang Tzung Lin

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Cell-based systems are useful for discovering antiviral agents. Dissecting the viral life cycle, particularly the early entry stages, allows a mechanistic approach to identify and evaluate antiviral agents that target specific steps of the viral entry. In this report, the methods of examining viral inactivation, viral attachment, and viral entry/fusion as antiviral assays for such purposes are described, using hepatitis C virus as a model. These assays should be useful for discovering novel antagonists/inhibitors to early viral entry and help expand the scope of candidate antiviral agents for further drug development.

Original languageEnglish
Article numbere53124
JournalJournal of Visualized Experiments
Volume2015
Issue number104
DOIs
Publication statusPublished - Oct 29 2015

Fingerprint

Antiviral agents
Antiviral Agents
Assays
Virus Inactivation
Viruses
Life cycle
Fusion reactions
Life Cycle Stages
Hepacivirus
Pharmaceutical Preparations

Keywords

  • Antiviral activity
  • Drug development
  • Early viral entry
  • Immunology
  • Issue 104
  • Viral attachment/binding
  • Viral entry/fusion
  • Viral inactivation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemical Engineering(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)

Cite this

Early viral entry assays for the identification and evaluation of antiviral compounds. / Tai, Chen Jei; Li, Chia Lin; Tai, Cheng Jeng; Wang, Chien Kai; Lin, Liang Tzung.

In: Journal of Visualized Experiments, Vol. 2015, No. 104, e53124, 29.10.2015.

Research output: Contribution to journalArticle

@article{28b3b3c7b6b444fa8e8edb53ca04bf55,
title = "Early viral entry assays for the identification and evaluation of antiviral compounds",
abstract = "Cell-based systems are useful for discovering antiviral agents. Dissecting the viral life cycle, particularly the early entry stages, allows a mechanistic approach to identify and evaluate antiviral agents that target specific steps of the viral entry. In this report, the methods of examining viral inactivation, viral attachment, and viral entry/fusion as antiviral assays for such purposes are described, using hepatitis C virus as a model. These assays should be useful for discovering novel antagonists/inhibitors to early viral entry and help expand the scope of candidate antiviral agents for further drug development.",
keywords = "Antiviral activity, Drug development, Early viral entry, Immunology, Issue 104, Viral attachment/binding, Viral entry/fusion, Viral inactivation",
author = "Tai, {Chen Jei} and Li, {Chia Lin} and Tai, {Cheng Jeng} and Wang, {Chien Kai} and Lin, {Liang Tzung}",
year = "2015",
month = "10",
day = "29",
doi = "10.3791/53124",
language = "English",
volume = "2015",
journal = "Journal of Visualized Experiments",
issn = "1940-087X",
publisher = "MYJoVE Corporation",
number = "104",

}

TY - JOUR

T1 - Early viral entry assays for the identification and evaluation of antiviral compounds

AU - Tai, Chen Jei

AU - Li, Chia Lin

AU - Tai, Cheng Jeng

AU - Wang, Chien Kai

AU - Lin, Liang Tzung

PY - 2015/10/29

Y1 - 2015/10/29

N2 - Cell-based systems are useful for discovering antiviral agents. Dissecting the viral life cycle, particularly the early entry stages, allows a mechanistic approach to identify and evaluate antiviral agents that target specific steps of the viral entry. In this report, the methods of examining viral inactivation, viral attachment, and viral entry/fusion as antiviral assays for such purposes are described, using hepatitis C virus as a model. These assays should be useful for discovering novel antagonists/inhibitors to early viral entry and help expand the scope of candidate antiviral agents for further drug development.

AB - Cell-based systems are useful for discovering antiviral agents. Dissecting the viral life cycle, particularly the early entry stages, allows a mechanistic approach to identify and evaluate antiviral agents that target specific steps of the viral entry. In this report, the methods of examining viral inactivation, viral attachment, and viral entry/fusion as antiviral assays for such purposes are described, using hepatitis C virus as a model. These assays should be useful for discovering novel antagonists/inhibitors to early viral entry and help expand the scope of candidate antiviral agents for further drug development.

KW - Antiviral activity

KW - Drug development

KW - Early viral entry

KW - Immunology

KW - Issue 104

KW - Viral attachment/binding

KW - Viral entry/fusion

KW - Viral inactivation

UR - http://www.scopus.com/inward/record.url?scp=84946430169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946430169&partnerID=8YFLogxK

U2 - 10.3791/53124

DO - 10.3791/53124

M3 - Article

C2 - 26555014

AN - SCOPUS:84946430169

VL - 2015

JO - Journal of Visualized Experiments

JF - Journal of Visualized Experiments

SN - 1940-087X

IS - 104

M1 - e53124

ER -